INTRACRANIAL TUMOUR HAEMORRHAGE side effect
What is INTRACRANIAL TUMOUR HAEMORRHAGE ?INTRACRANIAL TUMOUR HAEMORRHAGE : Temodal Side Effects Report #5548168-8
Physician from JAPAN reported TEMODAL problem on Nov 29, 2007. Female patient, 41 years of age, was diagnosed with malignant glioma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: intracranial tumour haemorrhage, intraocular pressure increased, . TEMODAL dosage: 75 MG/M2;QD;PO. Patient died on 11/19/2007.
INTRACRANIAL TUMOUR HAEMORRHAGE : Trastuzumab Side Effects Report #5514856-2
TRASTUZUMAB problem was reported by a Physician from UNITED KINGDOM on Oct 29, 2007. Female patient, weighting 154.3 lb, was treated with TRASTUZUMAB. After drug was administered, patient experienced the following problems/side effects: intracranial tumour haemorrhage, . TRASTUZUMAB dosage: 150 MG, UNK. During the same period patient was treated with PACLITAXEL, BONDRONAT. Patient was hospitalized. Patient recovered.
INTRACRANIAL TUMOUR HAEMORRHAGE : Avonex Side Effects Report #5500684-0
Physician from UNITED STATES reported AVONEX problem on Oct 15, 2007. Female patient, 56 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: intracranial tumour haemorrhage, . AVONEX dosage: unknown. Patient died on 07/01/2007.
INTRACRANIAL TUMOUR HAEMORRHAGE : Temodal Side Effects Report #5385149-1
TEMODAL problem was reported by a Physician from JAPAN on July 05, 2007. Male patient, 71 years of age, weighting 114.6 lb, was diagnosed with malignant oligodendroglioma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: intracranial tumour haemorrhage, lymphocyte count decreased, pneumonia, . TEMODAL dosage: 75 MG/M2; QD; PO. During the same period patient was treated with BAKTAR, TAKEPRON OD, AMLODIN, DIOVAN, ASPIRIN, URSO, PREDNISOLONE, AZULFIDINE EN. Patient died on 05/25/2007.
INTRACRANIAL TUMOUR HAEMORRHAGE : Temodal Side Effects Report #5385149-1
Physician from JAPAN reported TEMODAL problem on July 05, 2007. Male patient, 71 years of age, weighting 114.6 lb, was diagnosed with malignant oligodendroglioma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: intracranial tumour haemorrhage, lymphocyte count decreased, pneumonia, . TEMODAL dosage: 75 MG/M2; QD; PO. During the same period patient was treated with BAKTAR, TAKEPRON OD, AMLODIN, DIOVAN, ASPIRIN, URSO, PREDNISOLONE, AZULFIDINE EN. Patient died on 05/25/2007.
INTRACRANIAL TUMOUR HAEMORRHAGE : Trastuzumab Side Effects Report #5531823-3
TRASTUZUMAB problem was reported by a Physician from UNITED KINGDOM on Nov 23, 2007. Female patient, weighting 154.3 lb, was treated with TRASTUZUMAB. After drug was administered, patient experienced the following problems/side effects: disease progression, intracranial tumour haemorrhage, . TRASTUZUMAB dosage: 150 MG, UNK. During the same period patient was treated with PACLITAXEL, BONDRONAT. Patient was hospitalized. Patient died on 11/06/2007.
INTRACRANIAL TUMOUR HAEMORRHAGE : Trastuzumab Side Effects Report #5546341-6
Physician from UNITED KINGDOM reported TRASTUZUMAB problem on Nov 26, 2007. Female patient, weighting 154.3 lb, was diagnosed with breast cancer metastatic and was treated with TRASTUZUMAB. After drug was administered, patient experienced the following problems/side effects: disease progression, intracranial tumour haemorrhage, polyneuropathy, . TRASTUZUMAB dosage: 150 MG, UNK. During the same period patient was treated with PACLITAXEL, BONDRONAT, TAMOXIFEN CITRATE, ZOLADEX, CISPLATIN, CYCLOPHOSPHAMIDE, EPIRUBICIN, ETOPOSIDE. Patient was hospitalized. Patient died on 11/06/2007.
INTRACRANIAL TUMOUR HAEMORRHAGE : Temodal Side Effects Report #5578527-9
TEMODAL problem was reported by a Physician from JAPAN on Dec 21, 2007. Male patient, 66 years of age, weighting 110.2 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: disease progression, intracranial tumour haemorrhage, . TEMODAL dosage: 150 MG/M2; QD; PO; 150 MG/M2; QD; PO; 150 MG/M2; QD; PO. During the same period patient was treated with NATULAN, CYMERIN, ONCOVIN, DEPAKENE. Patient died on 04/25/2007.
INTRACRANIAL TUMOUR HAEMORRHAGE : Topotecan Side Effects Report #5456558-7
Consumer or non-health professional from UNITED STATES reported TOPOTECAN problem on Sept 05, 2007. Female patient was treated with TOPOTECAN. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, intracranial tumour haemorrhage, . TOPOTECAN dosage: unknown. During the same period patient was treated with FILGRASTIM, PENTAMIDINE ISETHIONATE. Patient recovered.
INTRACRANIAL TUMOUR HAEMORRHAGE : Nexavar Side Effects Report #5574712-0
NEXAVAR problem was reported by a Health Professional from UNITED STATES on Dec 20, 2007. Male patient, 36 years of age, weighting 141.1 lb, was diagnosed with metastatic malignant melanoma and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: aphasia, hemiparesis, intracranial tumour haemorrhage, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
INTRACRANIAL TUMOUR HAEMORRHAGE : Temodal Side Effects Report #5492796-5
Physician from JAPAN reported TEMODAL problem on Jan 24, 2007. Female patient, 42 years of age, weighting 145.5 lb, was diagnosed with anaplastic astrocytoma, neoplasm recurrence and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, hepatic function abnormal, intracranial tumour haemorrhage, . TEMODAL dosage: 150 MG/M2;QD;PO. During the same period patient was treated with NIDRAN, PHENYTOIN CAP, BISOLVON, SUCRALFATE, THYRADIN S, ZANTAC. Patient recovered.
INTRACRANIAL TUMOUR HAEMORRHAGE : Temodal Side Effects Report #5383073-1
TEMODAL problem was reported by a Physician from ISRAEL on June 28, 2007. Female patient, 57 years of age, weighting 147.7 lb, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: asthenia, hypokalaemia, intracranial tumour haemorrhage, leukopenia, pseudomonas infection, thrombocytopenia, transfusion reaction, . TEMODAL dosage: unknown. During the same period patient was treated with SULPHAMETHOXAZOLE, TRIMETHOPRIM. Patient was hospitalized. Patient died on 05/24/2007.
INTRACRANIAL TUMOUR HAEMORRHAGE : Nexavar Side Effects Report #5393779-6
Health Professional from UNITED STATES reported NEXAVAR problem on July 16, 2007. Male patient, 36 years of age, weighting 141.1 lb, was diagnosed with metastatic malignant melanoma and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: aphasia, hemiparesis, intracranial tumour haemorrhage, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
INTRACRANIAL TUMOUR HAEMORRHAGE : Temodal Side Effects Report #5383073-1
TEMODAL problem was reported by a Physician from ISRAEL on June 28, 2007. Female patient, 57 years of age, weighting 147.7 lb, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: asthenia, hypokalaemia, intracranial tumour haemorrhage, leukopenia, pseudomonas infection, thrombocytopenia, transfusion reaction, . TEMODAL dosage: unknown. During the same period patient was treated with SULPHAMETHOXAZOLE, TRIMETHOPRIM. Patient was hospitalized. Patient died on 05/24/2007.
INTRACRANIAL TUMOUR HAEMORRHAGE : Nexavar Side Effects Report #5393779-6
Health Professional from UNITED STATES reported NEXAVAR problem on July 16, 2007. Male patient, 36 years of age, weighting 141.1 lb, was diagnosed with metastatic malignant melanoma and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: aphasia, hemiparesis, intracranial tumour haemorrhage, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.